Advances in the Management of Pemphigus Vulgaris: A Review Article
Keywords:
flaccid bulla, desmosomes, nikolsky sign, asboe-hansen sign, immunofluorescence
Abstract
Abstract not found
Downloads
How to Cite
References
Jean-Claude Bystryn (1996) The Adjuvant Therapy of Pemphigus. 132(2), 203.
Kyriakos Kyriakis Md, Androniki Tosca Md (1998) Epidemiologic observations on the natural course of pemphigus vulgaris. 37(3), 215-219.
D Kuriachan, R Suresh, M Janardhanan, V Savithri (2015) Oral lesions: The Clue to Diagnosis of Pemphigus Vulgaris. 2015, 593940.
A Gambino, M Carbone, P Arduino, P Carcieri, L Carbone, R Broccoletti (2014) Conservative Approach in Patients with Pemphigus Gingival Vulgaris: A Pilot Study of Five Cases. 747506.
P Joly, N Litrowski (2011) Pemphigus Group (Vulgaris, Vegetans, Foliaceus, Herpetiformis, Brasiliensis). 29(4), 432-436.
S Pisanti, Y Sharav, E Kaufman, L Posner (1974) Pemphigus vulgaris: Incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. 38(3), 382-387.
Sara Wertenteil, Amit Garg, Andrew Strunk, Allireza Alloo (2019) Prevalence Estimates for Pemphigus in the United States. 155(5), 627.
David Garrod, Martyn Chidgey (2008) Desmosome structure, composition and function. 1778(3), 572-587.
P Joly, B Horvath, Α Patsatsi, S Uzun, R Bech, S Beissert, R Bergman, P Bernard, L Borradori, M Caproni, F Caux, G Cianchini, M Daneshpazhooh, D De, M Dmochowski, K Drenovska, J Ehrchen, C Feliciani, M Goebeler, R Groves, C Guenther, S Hofmann, D Ioannides, C Kowalewski, R Ludwig, Y Lim, B Marinovic, A Marzano, J Mascaró, D Mimouni, D Murrell, C Pincelli, C Squarcioni, M Sárdy, J Setterfield, E Sprecher, S Vassileva, K Wozniak, S Yayli, G Zambruno, D Zillikens, M Hertl, E Schmidt (2020) Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV). 34(9), 1900-1913.
Msendhil Kumaran, Amrinder Kanwar, Divya Seshadri (2013) Acantholysis revisited: Back to basics. 79(1), 120.
M Kavala, S Altıntaş, E Kocatürk, İ Zindancı, B Can, Ç Ruhi, Z Turkoglu (2011) Ear, nose and throat involvement in patients with pemphigus vulgaris: correlation with severity, phenotype and disease activity. 25(11), 1324-1327.
Mukaddes Kavala, Filiz Topaloğlu Demir, Ilkin Zindanci, Burce Can, Zafer Turkoğlu, Ebru Zemheri, Osman Cam, Ahmet Teksen (2015) Genital involvement in pemphigus vulgaris (PV): Correlation with clinical and cervicovaginal Pap smear findings. 73(4), 655-659.
Sentamilselvi Ganapati (2014) Eponymous dermatological signs in bullous dermatoses. 59(1), 21.
William James, Dirk Elston, Patrick Mcmahon (2005) Chronic Blistering Dermatoses. 309-322.
S Cheng, M Kobayashi, A Tanikawa, K Kinoshita-Kuroda, M Amagai, T Nishikawa (2002) Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. 147(2), 261-265.
M Daneshpazhooh, Zafarmand Sedigh, V Balighi, K (2016) Immunologic Prediction of Relapse in Patients with Pemphigus Vulgaris (PV) in Clinical Remission. 74, 1160-1165.
M Saleh (2018) A Prospective Study Comparing Patients with Early and Late Relapsing Pemphigus Treated with Rituximab. 79, 97-103.
Jean-Claude Bystryn, Jennifer Rudolph (2005) Pemphigus. 366(9479), 61-73.
Ronald Moy, Robert Jordon (1983) Immunopathology in pemphigus. 1(2), 72-81.
M Pfutze, A Niedermeier, M Hertl, R Eming (2007) Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus. 17, 4-11.
Dedee Murrell, Sarah Dick, A Ahmed, Masayuki Amagai, Maria Barnadas, Luca Borradori, Jean-Claude Bystryn, Giuseppe Cianchini, Luis Diaz, David Fivenson, Russell Hall, Karen Harman, Takashi Hashimoto, Michael Hertl, Nico Hunzelmann, Pilar Iranzo, Pascal Joly, Marcel Jonkman, Yasuo Kitajima, Neil Korman, Linda Martin, Daniel Mimouni, Amit Pandya, Aimee Payne, David Rubenstein, Hiroshi Shimizu, Animesh Sinha, David Sirois, Detlef Zillikens, Victoria Werth (2008) Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. 58(6), 1043-1046.
Benjamin Daniel, Michael Hertl, Victoria Werth, Rüdiger Eming, Dédée Murrell (2012) Severity score indexes for blistering diseases. 30(1), 108-113.
Cheyda Chams-Davatchi, Nafiseh Esmaili, Maryam Daneshpazhooh, Mahin Valikhani, Kamran Balighi, Zahra Hallaji, Masoumeh Barzegari, Maryam Akhyani, S Ghodsi, Hassan Seirafi, Mohammad-Javad Tabrizi Nazemi, Hossein Mortazavi, Mostafa Mirshams-Shahshahani (2007) Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. 57(4), 622-628.
William Sanders (2017) A brief review of pemphigus vulgaris. 1(1), 7.
S Meggitt, A Anstey, M Mohd Mustapa, N Reynolds, S Wakelin, M Tidman, L Fuller, J Mclelland, J Lear, J Hughes, A Mcdonagh, S Punjabi, N Morar, D Buckley, I Nasr, P Maycock, S Amin, S Hulley, S Haveron (2011) British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011. 165(4), 711-734.
O Mohammadi, T Kassim (2021) StatPearls [Internet.
Robert Weinstein (2012) Glucocorticoid-Induced Osteoporosis and Osteonecrosis. 41(3), 595-611.
Y Puckett, A Gabbar, A Bokhari (2021) StatPearls [Internet.
S Treon, K Anderson (2000) The Use of Rituximab in the Treatment of Malignant and Nonmalignant Plasma Cell Disorders. 27, 79-85.
M Arin, A Engert, T Krieg, N Hunzelmann (2005) Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. 153(3), 620-625.
Victoria Werth, Pascal Joly, Daniel Mimouni, Emanual Maverakis, Frédéric Caux, Patricia Lehane, Liudmila Gearhart, Audrey Kapre, Pooneh Pordeli, Diana Chen (2021) Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris. 384(24), 2295-2305.
Lauren Albers, Yuan Liu, Na Bo, Robert Swerlick, Ron Feldman (2017) Developing biomarkers for predicting clinical relapse in pemphigus patients treated with rituximab. 77(6), 1074-1082.
G Genovese, C Maronese, G Casazza, L Corti, L Venegoni, S Muratori, E Berti, D Fanoni, A Marzano (2022) Clinical and serological predictors of relapse in pemphigus: a study of 143 patients. 47(1), 98-106.
Maud Maho-Vaillant, Corine Perals, Marie-Laure Golinski, Vivien Hébert, Frédérique Caillot, Claire Mignard, Gaëtan Riou, Marie Petit, Manuelle Viguier, Michael Hertl, Olivier Boyer, Sébastien Calbo, Nicolas Fazilleau, Pascal Joly (2021) Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus. 141(9), 2132-2140.e1.
A Dupuy, M Viguier, C Et Bedane, Al (2004) Treatment of Refractory Pemphigus Vulgaris with Rituximab (Anti-CD20 Monoclonal Antibody). 140, 91-96.
O Benjamin, P Bansal, A Goyal, S Lappin (2021) StatPearls [Internet.
Published
2022-09-17
Issue
Section
License
Copyright (c) 2022 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.